In summary, our results indicate that the ERp57/STAT3/ILF3 feedback loop plays a key role in the oncogenesis of ccRCC and provides a potential therapeutic target for ccRCC treatment. The gene discussed is STAT3; the disease is nonpapillary renal cell carcinoma.